SMO ClinPlus Co. Ltd. (301257) — Cash Flow Reinvestment Rate

Latest as of December 2025: 2.87x

SMO ClinPlus Co. Ltd. (301257) has a Cash Flow Reinvestment Rate of 2.87x as of December 2025, reinvesting CN¥102.61 Million (capex CN¥7.83 Million plus investments CN¥94.78 Million) from operating cash flow of CN¥35.69 Million. See SMO ClinPlus Co. Ltd. (301257) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.87x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥102.61 Million
Capex + Investments

Operating Cash Flow

CN¥35.69 Million
CNY

Capital Expenditures

CN¥7.83 Million
CNY

SMO ClinPlus Co. Ltd. Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for SMO ClinPlus Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of SMO ClinPlus Co. Ltd..

Annual Cash Flow Reinvestment Rate for SMO ClinPlus Co. Ltd. (2019–2025)

Year-by-year capital reinvestment analysis for SMO ClinPlus Co. Ltd.. See 301257 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.87x CN¥102.61 Million CN¥35.69 Million CN¥7.83 Million ▲ +12.0%
2023 2.57x CN¥294.70 Million CN¥114.85 Million CN¥10.25 Million ▼ -30.9%
2022 3.71x CN¥150.07 Million CN¥40.44 Million CN¥7.95 Million ▲ +1653.2%
2021 0.21x CN¥8.79 Million CN¥41.52 Million CN¥4.40 Million ▼ -41.7%
2020 0.36x CN¥8.15 Million CN¥22.45 Million CN¥4.08 Million ▼ -1.7%
2019 0.37x CN¥16.82 Million CN¥45.53 Million CN¥4.91 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow